Target intelligence / Profile preview

Dynactin 4 pseudogene (ENSG00000227722)

Target
ENSG00000227722
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

The dynactin 4 pseudogene (ENSG00000227722) is a non-functional genomic sequence derived from the dynactin 4 gene (DCTN4), which encodes the p62 subunit of the dynactin complex. As a pseudogene, it has lost protein-coding capacity due to deleterious disruptions such as premature stop codons or frameshift mutations in its open reading frame[1]. Despite being considered "non-functional," this pseudogene may be transcribed to produce non-coding RNAs that could influence gene expression through various mechanisms[1]. Pseudogenes like this one can function as competing endogenous RNAs (ceRNAs), potentially affecting the expression of their parent genes through positive correlations in transcriptional profiles[1]. They may also produce small RNAs that can interfere with gene expression or participate in chromatin modification through recruitment of histone methyltransferases and establishment of repressive chromatin environments[1]. The parent dynactin 4 gene encodes a crucial component of the dynactin complex, which acts as an activator of cytoplasmic dynein and is involved in intracellular transport, mitosis, and nuclear migration[2]. The dynactin 4 subunit contains zinc-binding motifs and is part of the pointed-end complex of the dynactin structure[2]. While the pseudogene itself is not a therapeutic target, understanding its regulatory role may provide insights into cellular processes and potential disease mechanisms.

Other names
DCTN4 pseudogenedynactin subunit 4 pseudogenep62 pseudogene
02

Biological functions

Gene expression regulationChromatin modificationPost-transcriptional regulation
03

Disease associations

Other

Beyond the preview

Go deeper on Dynactin 4 pseudogene (ENSG00000227722).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynactin 4 pseudogene (ENSG00000227722).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call